Published in Indian Heart J on April 28, 2012
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med (1999) 29.32
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med (2002) 27.55
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med (1996) 15.04
Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med (2010) 14.43
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med (2003) 13.25
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (1999) 10.17
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med (1997) 10.02
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation (1991) 4.65
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation (2000) 4.12
Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation (2004) 2.81
Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials. Eur Heart J (2008) 2.37
Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. N Engl J Med (1999) 1.85
Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Eur Heart J (2010) 1.30
Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc Res (1997) 1.24
Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem (1994) 1.18
Beneficial effect of eplerenone on cardiac remodelling and electrical properties of the failing heart. J Renin Angiotensin Aldosterone Syst (2006) 1.04
Reduction of fibrosis-related arrhythmias by chronic renin-angiotensin-aldosterone system inhibitors in an aged mouse model. Am J Physiol Heart Circ Physiol (2010) 1.04
Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol (2000) 0.94
Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure. J Card Fail (2007) 0.93
Treatment with spironolactone for 24 weeks decreases the level of matrix metalloproteinases and improves cardiac function in patients with chronic heart failure of ischemic etiology. Can J Cardiol (2009) 0.89
Aldosterone impairs baroreflex sensitivity in healthy adults. Am J Physiol Heart Circ Physiol (2006) 0.89
Aldosterone induces electrical remodeling independent of hypertension. Int J Cardiol (2011) 0.86
Cost-effectiveness analysis of aldosterone blockade with eplerenone in patients with heart failure after acute myocardial infarction in the French context: the EPHESUS study. Arch Cardiovasc Dis (2008) 0.82
The effect of aldosterone antagonists for ventricular arrhythmia: a meta-analysis. Clin Cardiol (2010) 0.82
Aldosterone blockade attenuates development of an electrophysiological substrate associated with ventricular tachyarrhythmias in heart failure. Heart Rhythm (2009) 0.81
Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction <or=30%. Eur J Heart Fail (2006) 0.80
Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators. Europace (2010) 0.79
Spironolactone therapy is associated with reduced ventricular tachycardia rate in patients with cardiomyopathy. Pacing Clin Electrophysiol (2010) 0.79
[Effect of long term therapy with spironolactone on parameters of 24-hour heart rhythm variability and ventricular arrhythmias in patients with heart failure receiving optimal therapy]. Kardiologiia (2008) 0.77
Discharge against medical advice: how often do we intervene? J Hosp Med (2013) 2.00
Absent left and right superior vena cava and azygos continuation of inferior vena cava: a rare anomaly of systemic venous return. J Invasive Cardiol (2010) 0.83
Association of Helicobacter pylori infection with the development of colorectal polyps and colorectal carcinoma. South Med J (2011) 0.80
Pilot evaluation of the short-term effect of driving simulation on novice adolescent drivers. J Trauma Acute Care Surg (2013) 0.77
Plasmacytoma presenting as hematuria. Int J Hematol (2011) 0.75
In response to "discharge against medical advice: how often do we intervene?". J Hosp Med (2013) 0.75
All that glitters: sorafenib. Intern Med (2011) 0.75
Adherence to Preoperative Cardiac Clearance Guidelines in Hip Fracture Patients. J Orthop Trauma (2015) 0.75
Prevalence and Predictors of Hernia Infection: Does Gender Matter? Am Surg (2016) 0.75
Self-reported attitudes and behaviors of general surgery residents about ethical academic practices in test taking. Surgery (2010) 0.75
The colon in patients with ankylosing spondylitis and in normal controls in Bangladesh: a macroscopic and microscopic study. Clin Rheumatol (2009) 0.75